Inside the Company That ’s Hot Wiring Vaccine Research in the Race to Combat the Coronavirus
Three months. That’s as long as Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health, is willing to wait to get a vaccine candidate against the latest coronavirus that he can start testing in people. Since the virus was identified for the first time in people who fell ill with pneumonia-like symptoms in Wuhan, China, last December, the World Health Organization has declared this coronavirus outbreak, named 2019n-CoV, a public health emergency of international concern. In just over a month, more 11,000 people have tested positive for the virus in 18 countries, and more than 250 have died. When it comes to infectious diseases like this one, vaccines are the strongest weapons that health officials have. Getting vaccinated can protect people from getting infected in the first place, and if viruses or bacteria have nowhere to go, they have no way to spread from person to person. The problem is, vaccines take time to develop. Traditional methods, while extremely effective in controlling highly contagious diseases like measles, require growing large amounts of virus or bacteria, which takes months. Those microbes then become the key element in a vaccine — the so-called antigen that alerts the human immune system that some foreign interlopers have invaded the body and need to be evicted. However, researchers at Moderna Therapeutics, Cambridge, Mass., have developed a potential shortcut to this labor...
The US coronavirus death toll is nearing 11,000 as the country prepares for what the President said will be a "difficult" week and a half.
A majority of pregnant women who are diagnosed with coronavirus don't experience more severe illness than the general population, according to a new study.
Children diagnosed with coronavirus in the United States typically have mild cases, the Centers for Disease Controls and Prevention said in a report released Monday.
We are learning more about coronavirus symptoms every day. Here are 10 of the most common symptoms and what to do to keep you and your family safe.
In just six weeks, the US death toll from coronavirus went from zero to more than 10,000. Yet there are also signs of progress. More Americans are finding creative ways to help. And in the US epicenter of coronavirus, the worst might be over soon.
With tests in short supply as coronavirus cases rise and a hodgepodge of state reporting practices, coroners and medical examiners fear many Covid-19 deaths may go uncounted.
A senior White House official warned President Trump in January that a pandemic would cost millions of lives and trillions of dollars. Mr. Johnson, Britain ’s prime minister, asked the foreign secretary, Dominic Raab, to fill in “where necessary.”
A federal judge is refusing to block Los Angeles officials from shutting down gun stores as nonessential businesses during the coronavirus pandemic
Mainland China reported no coronavirus deaths for the first time since the pandemic began, and a drop in new cases, a day before the central city of Wuhan, where the virus emerged late in December, is set to lift its lockdown.
Worldwide, COVID-19 has taken almost 75,000 lives. The British prime minister was hospitalized Sunday.
More News: Allergy | Allergy & Immunology | Biology | China Health | Coronavirus | COVID-19 | Education | Emergency Medicine | Epidemics | Epidemiology | Genetics | Health | Infectious Diseases | International Medicine & Public Health | Measles | Measles Vaccine | National Institutes of Health (NIH) | Outbreaks | Pneomococcal Vaccine | Pneumonia | Vaccines | WHO | Wuhan Coronavirus